EndeavorRx
Commercial- Indications
- ADHD in children
Company intelligence / Profile preview
Akili Interactive developed the first FDA-cleared prescription video game treatment for pediatric ADHD. Clinical studies have shown statistically significant improvements in sustained attention in both children with ADHD and adults with major depressive disorder when used alongside standard treatments. The company’s products are delivered via engaging video games designed to directly activate brain networks responsible for cognitive function. No serious adverse events were reported in clinical trials.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Akili Interactive.